Navigation Links
Kentucky Pharmacists Urge Senator McConnell to Put Patients First
Date:12/6/2007

Removing discounted mail order and pharmacy benefit manager prices that are unavailable to community pharmacies and unfairly lowers the overall AMP formula.

-- Requiring Medicaid payment to be calculated using the weighted average of the Medicaid generic drugs based on utilization.

-- Restoring the previous practice of using three available generic products in calculating the Federal Upper Limits that are used for setting adequate pharmacy reimbursements.

-- Increasing Medicaid reimbursement from 250 percent of the AMP to 300 percent in order to ensure pharmacies are not reimbursed below their acquisition costs.

-- Encouraging more inexpensive generic drug usage by requiring prior authorization of brand name drugs.

"Who can stay in business at 36% below cost?" said Brad Hall, executive director of the Kentucky Pharmacists Association. "The federal government's AMP formula does not properly measure retail acquisition costs for community pharmacies like Capital Pharmacy and Medical Equipment here in Frankfort. The real world consequences of this disastrous federal policy will be felt most profoundly by patients, who will see their access to prescription drugs and the valued expertise of their trusted local pharmacists undermined. When that happens these patients will be forced to more expensive options such as visiting emergency rooms. This can all be avoided if Congress acts before the rule is fully implemented on January 30, 2008."

Also in attendance was Larry Hadley, co-owner of Wayne's Pharmacy, which is also in Frankfort, Ky. He provided additional insight into the fallout his business and patients would experience if Congress doesn't act to change or at least delay the AMP rule. "After five years of working to build up my business, I am very concerned about what the future holds," said Hadley. "All you have to do is a little math to understand the numbers don't add up under AMP. Hopefully, Sen. McConnell wil
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
2. Nurses From Across Nation Join Solidarity Caravan in Support of Striking Kentucky RNs
3. Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index
4. Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule
5. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
6. CVS Caremark Celebrates American Pharmacists Month by Thanking Its 20,000 Pharmacists
7. Maryland Pharmacists Urge House Majority Leader Hoyer to Put Patients First
8. Lisa Camooso Miller Joins National Community Pharmacists as Vice President of Public Affairs
9. By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales
10. CVS Pharmacists Serve a Vital Role in Helping Patients Manage Diabetes
11. Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Protect Investment And Restore Shareholder Value ...ire/ -- Dr. Stephen Joffe, Craig Joffe, and Alan B...3D with the U.S. Securities and Exchange Commissio...nership of 11.4% of LCA-Vision, Inc. (Nasdaq: LC... vision correction centers in 33 states in the Uni...
(Date:11/21/2008)...stCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL...ingly approved the proposals submitted to them rel...ticals Industries Ltd. (Nasdaq: TEVA ). , ,...pport of the transaction by the Barr shareholders,...We are pleased with the progress that we continue ...
(Date:11/21/2008)...atewide survey, 33 physicians credentialed to prac...erian Hospital of Dallas were honored by Texas Mo...rs ." , , Each year, the publishers of Tex... to survey more than 38,000 medical professionals ...edical care, which doctor would you choose?" Key ...
(Date:11/21/2008)...ope Research(TM), a revolutionary,biometric media...Measurement,announced today the appointment of t... research and development, business strategy and m...ents, who deliver a combined 60 years of experienc...er and Vice President of,Strategy; Dr. Ravi Kothu...
Breaking Medicine News(10 mins):Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...dministration ordered the makers of ADHD drugs to ...ients, the significant// ones being psychiatric an...or of the FDA’s Center for Drug Evaluation and Res... immensely useful in treating patients with ADHD, ...
... degeneration (AMD) is the leading cause of visual...50, affecting// more than two million people. Th...d people that although AMD is incurable, there are...sually recover lost vision and prevent further vis...
... safe and healthy multivitamin? Vitamins and Miner...ard Medical School//, offers the following advice....t bear the U.S. Pharmacopeia Dietary Supplement Ve... mark, which indicates that the manufacturer has c...
...dia has immensely deteriorated over the last seven...t victims//, top UNICEF officials said Wednesday. ...I, (NFHS-3), over 56.2 percent married women in th...49 were anemic in 2006 as against 51.8 percent in ...
Other Medicine News:Health News:Spring is Time for Age-Related Macular Degeneration (AMD) Awareness 2Health News:Married Women, Children Most Anemic in India 2
(Date:11/21/2008).../ -- Ikaria Holdings, Inc. today announced that it... New Jersey Technology Council (NJTC), a 1,200-mem... support, networking opportunities, information an...ers. Ikaria earned the award based on criteria inc...e provision. , , "We are delighted that the...
(Date:11/20/2008)...F FIRST PHASE III TRIAL SHOW SIGNIFICANT, DEC...LY FUNCTION, IN, FIBRO...SSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/,--...UCB (Euronext Brussels: UCB),announced today posi...f two,Phase III pivotal clinical trials of sodium...
(Date:11/20/2008)...ire/ -- Radius Health ("Radius") announced today t... second institutional financing round, increasing ... total amount raised since the company,s inception...estors participated in the financing, led by MPM B..., The Wellcome Trust, HealthCare Ventures, Oxford ...
(Date:11/19/2008)...Newswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) an...diary of,Takeda Pharmaceutical Company Limited (T... Phase 3 MONET1 trial evaluating motesanib (AMG 70... for the first-line treatment of,advanced non-sma...uspended,following a planned safety data review o...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Physicians Health Choice Hires Blue Clover as Agency of Record 26590 1Physicians Health Choice Hires Blue Clover as Agency of Record 26590 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 1DRE Medical Equipment Offers Valuable Discounts to GE Healthcare Customers 26586 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 1Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 2Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 3Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 4Baby Boomers 26apos 3B Aging Wave Affects Social Security Disability Program 26583 5
...st clinical study of,HGS-ETR1 -, ROCKVILLE, Md., A...me Sciences, Inc. today reported that clinical and...ating that its TRAIL receptor,antibodies, HGS-ETR1...gnificant potential for use in the treatment of a ...1 and HGS-ETR2 could offer novel, highly,targeted ...
... - Insmed Inc.,(Nasdaq:INSM) today announced posi...d clinical study of the company,s drug,IPLEX(TM) i...ed,Adipose Redistribution Syndrome (HARS)., Prelim...he,University of California, San Francisco, showed...t in seven patients increased IGF-I,levels 3-fold ...
Other Medicine Technology:Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips.
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures.
Platinum General Purpose Cautery Electrodes , ,A - Loop Tip, ,Fully autoclavable. Tips typically last for 50 to 100 or more procedures, depending on burn time.
Medicine Products: